Related Experiment Video
Updated: Mar 27, 2026

11:07
Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation
Published on: July 6, 2019
27.3K
Harmine Derivatives Alleviate LPS-Induced Acute Lung Injury via Targeting GSK3β
Xinhui Ye1,2, Junjie Lin1,2, Tianqi Zhang1,2
1Department of Pharmacy, General Hospital of Northern Theater Command, Shenyang, 110016, P. R. China.
Inflammation
|March 25, 2026
Summary
No abstract available in PubMed .
Related Concept Videos
Antiasthma Drugs: Leukotriene Modifiers
2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.2K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
597
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
597

